Background Several trials have considered the safety and clinical benefits of colchicine as a
treatment option for secondary prevention in patients with coronary atherosclerotic heart …

Colchicine has shown potential therapeutic benefits in cardiovascular conditions owing to its
broad anti-inflammatory properties. Here, we performed a meta-analysis to determine the …

Background Inflammation plays a pivotal role in coronary artery disease (CAD). The anti‐
inflammatory drug colchicine seems to reduce ischemic events in patients with CAD. So far …

Several randomized controlled trials have studied the role of colchicine, a potent anti-
inflammatory drug, to prevent adverse cardiovascular events in patients with coronary artery …

To evaluate the efficacy and safety of colchicine for secondary prevention of coronary heart
disease (CHD), relevant randomized controlled trials (RCTs) were identified by searching …

Background: The authors examined the association between colchicine treatment and
clinical outcomes in patients with coronary artery disease. Methods: They performed a meta …

Background Inflammatory plays a key role in the development of coronary artery disease
(CAD). Colchicine as an anti-inflammatory treatment for CAD has attracted much attention …

Background Colchicine has become prominent as an anti-inflammatory therapy for
secondary cardiovascular prevention in patients with coronary artery disease (CAD). This …

Background Reduction of inflammation with colchicine has emerged as a therapeutic option
for secondary prevention of cardiovascular disease (CVD) in patients with coronary artery …

Aims The key role of inflammation in the pathogenesis of coronary artery disease (CAD) is
an urgent call for innovative treatments. Several trials have proposed colchicine as a …